EART yields 0.60% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, EART + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EART + MRK for your $10,000?
DMAT tracks an index of global stocks that produce metals and other raw materials essential to the expansion of disruptive technologies. Disruptive Materials Companies derive at least 50% of their revenues from the exploration, mining, production and/or enhancement of one or more of 10 materials categories that include Rare Earth Materials, Lithium, Copper, Carbon Fiber, etc. Stocks not meeting the revenue requirements are considered after review and recognized as Pre-Revenue Disruptive Materials Companies. In the case of Lithium, stocks with associated revenue between 25-50% are also eligible as Diversified Lithium Companies. The fund uses a natural language processing algorithm to identify and rank stocks. The five highest-ranked Disruptive Materials and Pre-Revenue Disruptive Materials Companies per materials category are selected. The fund employs a modified market-cap weighting scheme for diversification. The index is reconstituted and rebalanced semi-annually.
Full EART Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.